Announced Thu, 28 May · 19:49 IST

Audited Standalone & Consolidated Financial Results of the Company for the half-year and financial year ended March 31, 2026, along with the reports of the Statutory Auditor thereon approved ....

Revenue DeclineNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.8%1-day move
₹62.00
prior close
₹59.02
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.8+22.0+22.0+22.0+9.8+6.1+1.5-6.5+8.1-11.3
Up moveDown movePending
AI summary

Valencia Nutrition Ltd reported audited financial results for FY 2025-26. Standalone revenue from operations declined to Rs. 847.09 lakhs from Rs. 912.01 lakhs in the previous year, a drop of about 7%. Profit after tax (standalone) stood at Rs. 103.72 lakhs compared to Rs. 107.41 lakhs, marginally lower. Consolidated PAT was Rs. 109.27 lakhs. The company is in business-building mode with two new subsidiaries incorporated during the year - Valencia Cielo Libre Beverages (Spain) and Valencia Nutracare Lifesciences (75% holding). Statutory auditors issued unmodified opinions on both standalone and consolidated results. The Board also noted and resolved a BSE non-compliance notice with penalties fully paid.

Likely market impact

Revenue decline of 7% and significant negative operating cash flow of Rs. 1,943.50 lakhs (standalone) indicate working capital stress during expansion. However, clean audit opinions and resolution of compliance issues provide some comfort. The company is investing heavily in capacity expansion which may pressure short-term profitability.